Dr. Grunseich interview "Understanding Spinal-Bulbar Muscular Atrophy"
AnnJi Pharmaceutical Co., Ltd. and Avenue Therapeutics are excited to announce that Mike S. is the first Kennedy’s Disease patient to participate in the clinical trial of AJ201 at the University of California, Irvine.
